Vanguard VXUS vs SPDR SPGM: Expense, Yield and Scope Drive Value Gap

Why It Matters

The VXUS‑SPGM comparison matters because it highlights how small fee differentials and yield gaps can compound into sizable differences in investor outcomes over decades. As retirement accounts and robo‑advisors scale, the aggregate cost savings from lower‑expense ETFs like VXUS can translate into billions of dollars retained for investors. Moreover, the choice between an international‑only fund and a truly global fund reflects deeper portfolio construction philosophies. In a market environment where U.S. equities have historically driven returns, the inclusion of domestic stocks in SPGM can boost performance, but it also reduces diversification benefits. Understanding these nuances helps investors align ETF selection with risk tolerance, income needs, and long‑term growth objectives.

Key Takeaways

• VXUS expense ratio: 0.05% vs SPGM 0.09%, a 0.04% annual cost advantage.
• Trailing‑12‑month yield: VXUS 2.70% ($2.29/share) vs SPGM 1.70% ($1.45/share).
• U.S. exposure: SPGM holds 62% U.S. stocks; VXUS holds 0% U.S. stocks.
• Top holdings differ: SPGM’s largest positions are Nvidia, Apple, Microsoft; VXUS’s are TSMC, Samsung, ASML.
• Sector balance: SPGM tech 25%; VXUS tech 16% with broader financial and industrial exposure.

Pulse Analysis

From a market‑structure perspective, the fee race among index providers is reaching a point of diminishing returns. Vanguard’s 0.05% fee on VXUS is already near the floor of what active management can sustainably charge, and the incremental 0.04% saved versus SPGM becomes a decisive factor for large institutional investors whose allocations run into the billions. The yield premium further sweetens VXUS for income‑focused investors, especially as global dividend yields have risen relative to the near‑zero yields on U.S. Treasury bonds.

However, the performance narrative cannot be ignored. SPGM’s inclusion of the U.S. market—home to the Magnificent Seven—means it has historically outperformed pure international funds during periods of U.S. market strength. This creates a subtle but real trade‑off: lower cost and higher yield versus higher expected return. Portfolio managers must weigh the marginal cost savings against the potential alpha lost by excluding the U.S. market’s growth engine.

Looking forward, the competitive dynamics may shift if State Street narrows the fee gap or if Vanguard expands VXUS to include a modest U.S. tilt. Until then, the decision line remains clear: cost‑sensitive, diversification‑driven investors gravitate to VXUS, while those prioritizing total‑world exposure and willing to pay a premium lean toward SPGM. The ongoing battle for the lowest‑cost, highest‑coverage ETF will likely spur further fee compression and product innovation across the industry.